Telangana Cracks Down on Pharma Units Over Suspected Narcotics Precursor Production
Telangana Shuts Pharma Units in Narcotics Precursor Crackdown

Telangana Authorities Shutter Pharma Units in Major Narcotics Precursor Crackdown

In a decisive move against suspected illegal precursor chemical operations, the Telangana Pollution Control Board, acting on intelligence from the Telangana Anti-Narcotics Bureau, has mandated the closure and electricity disconnection of three pharmaceutical facilities located in and around Hyderabad. This action stems from an extensive investigation into the alleged manufacturing and handling of chemical substances with potential ties to illicit narcotics production.

Forensic Probe Uncovers Regulatory Violations

Officials confirmed that the decision was reached after a comprehensive forensic examination, on-site inspections, and rigorous regulatory scrutiny of the units' activities. Investigators revealed that one of the companies was involved in producing 3-cyclopentylpropionyl chloride, a chemical identified by agencies as linked to the illicit synthesis of fentanyl, a potent synthetic opioid.

Another firm was found to be associated with the production of 4-methoxypropionophenone, recognized as a precursor used in manufacturing substituted cathinones, often referred to as "bath salts." At the third pharmaceutical unit, authorities discovered the storage of acetic anhydride without the mandatory approval from the narcotics department, raising significant regulatory red flags.

Drug precursors are essential chemicals utilized in the production of controlled substances such as heroin and cocaine, making their unauthorized handling a critical concern for law enforcement.

Surveillance and Regulatory Alerts Trigger Action

The case gained momentum after the Telangana Anti-Narcotics Bureau initiated tracing of suspicious chemical activities during raids on other unlicensed chemical and intermediate manufacturing units across the state. Earlier, in April 2025, the Drugs Control Administration had issued a surveillance alert, flagging the manufacture of certain chemicals with a high risk of diversion into banned narcotic or psychotropic substances.

In formal letters dated December 31, 2025, and January 8, 2026, the bureau requested the Pollution Control Board to examine the operations of two firms and verify manufacturing activities at the third pharmaceutical unit. The bureau informed the board that the first firm was allegedly producing 3-cyclopentylpropionyl chloride, while the second unit was manufacturing anisole for the production of 4-methoxypropionophenone.

Investigators also highlighted the absence of formal agreements, observation registers, and official documentation related to products allegedly manufactured in reactors taken on lease or operated at alternative facilities, further compounding regulatory breaches.

Immediate Closure and Power Disconnection Ordered

Following these findings, the Pollution Control Board ordered the immediate closure of all three units and directed the Telangana State Power Distribution Company Limited to disconnect electricity supply to prevent any further activity. Officials emphasized that this action aims to halt what investigators suspect may have been the use of industrial or research facilities for manufacturing precursor chemicals outside the established regulatory framework, pending additional investigation.

This crackdown underscores the ongoing efforts by Telangana authorities to combat the diversion of chemicals into illegal drug production networks, safeguarding public health and enforcing compliance with narcotics regulations.